Free Review Articles on Haut (Neoplasia Melanoma)                                 Metatextbook

Freie Reviews über Haut (Neubildung Melanom)                                 Look here for Journal Homepages

  • Haut (Neoplasia Melanoma)
  • Neoplasia (Paraneoplastic syndromes)
  • Melanoma associated retinopathy syndrome
  • Interferon alpha (Therapeutic use)
  • Melanocyte
  • Neoplasia (Carcinogenesis)
  • FLT1
  • KDR
  • NRP1
  • Melanosom
  • Lymph node (Metastasis and sentinel)
  • CTLA4
  • Ipilimumab
  • Tremelimumab
  • Temozolomide
  • Bortezomib
  • Neoplasia (Tumor biology and immunology)
  • Aneuploidity
  • CD152 CTLA4
  • BRAF
  • CNS (Metastasis)
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12009Cutaneous melanoma--atypical variants and presentations.



    		+-nlAust Fam Physician 38(7):476-82 (2009)
    22008Treatment of melanoma.



    		+-nlDtsch Arztebl Int 105(49):845-51 (2008)
    31973Studies of humoral and cell-mediated immunity in human melanoma.



    		+-nlYale J Biol Med 46(5):681-92 (1973)
    42001Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.



    		+-nlJ Neuroophthalmol 21(3):173-87 (2001)
    52010Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review.



    		+-nlCore Evid 5(-):39-48 (2010)
    62006Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas.



    		+-nlArch Dermatol 142(12):1551-8 (2006)
    72002Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases.



    		+-nlArch Dermatol 138(12):1562-6 (2002)
    82010From melanocyte to metastatic malignant melanoma.



    		+-nlDermatol Res Pract 2010(-):- (2010)
    92008Immunotherapy for advanced melanoma.



    		+-nlJ Invest Dermatol 128(11):2596-605 (2008)
    102008Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside.



    		+-nlJ Invest Dermatol 128(11):2575-95 (2008)
    112008From UVs to metastases: modeling melanoma initiation and progression in the mouse.



    		+-nlJ Invest Dermatol 128(10):2381-91 (2008)
    122008Melanoma, nevogenesis, and stem cell biology.



    		+-nlJ Invest Dermatol 128(10):2365-80 (2008)
    132007Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.



    		+-nlJ Invest Dermatol 127(4):900-5 (2007)
    142002Pathways to melanoma development: lessons from the mouse.



    		+-nlJ Invest Dermatol 119(4):783-92 (2002)
    152002The role of chemokines in melanoma tumor growth and metastasis.



    		+-nlJ Invest Dermatol 118(6):915-22 (2002)
    162007Hedgehog signaling in the murine melanoma microenvironment.



    		+-nlAngiogenesis 10(4):259-67 (2007)
    172005Inhibition of B16 melanoma growth in vivo by retroviral vector-mediated human ribonuclease inhibitor.



    		+-nlAngiogenesis 8(1):73-81 (2005)
    182003Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.



    		+-nlAngiogenesis 6(4):295-301 (2003)
    192002The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis.



    		+-nlTraffic 3(4):237-48 (2002)
    202009Molecular markers of tumor progression in melanoma.



    		+-nlCurr Genomics 10(4):231-9 (2009)
    212002Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision.



    		+-nlArch Surg 137(10):1101-5 (2002)
    221997Advances in the care of the patient with malignant melanoma.



    		+-nlAnn Surg 225(1):15-6 (1997) Seigler HF
    231997Recent advances in the care of the patient with malignant melanoma.



    		+-nlAnn Surg 225(1):1-14 (1997)
    241991Surgical prophylaxis of malignant melanoma.



    		+-nlAnn Surg 213(4):308-14 (1991)
    251977Current management of melanoma.



    		+-nlAnn Surg 186(1):1-12 (1977)
    262010Advanced malignant melanoma: immunologic and multimodal therapeutic strategies.



    		+-nlJ Oncol 2010(-):689893 (2010)
    272007Medical treatment of uveal melanoma.



    		+-nlTumori 93(3):suppl 27-30 (2007)
    282009Biomarkers in melanoma.



    		+-nlAnn Oncol 20 Suppl 6(-):vi8-13 (2009)
    292009Immunotherapy of distant metastatic disease.



    		+-nlAnn Oncol 20 Suppl 6(-):vi41-50 (2009)
    302009Small molecules and targeted therapies in distant metastatic disease.



    		+-nlAnn Oncol 20 Suppl 6(-):vi35-40 (2009)
    312009Utility of adjuvant systemic therapy in melanoma.



    		+-nlAnn Oncol 20 Suppl 6(-):vi30-4 (2009)
    322009Surgery and radiotherapy in the treatment of cutaneous melanoma.



    		+-nlAnn Oncol 20 Suppl 6(-):vi22-9 (2009)
    332009Staging of cutaneous melanoma.



    		+-nlAnn Oncol 20 Suppl 6(-):vi14-21 (2009)
    342008Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 19 Suppl 2(-):ii86-8 (2008)
    352000Malignant melanoma: prevention, early detection, and treatment in the 21st century.



    		+-nlCA Cancer J Clin 50(4):215-36; quiz 237-40 (2000)
    361996Surgical management of primary cutaneous melanoma.



    		+-nlCA Cancer J Clin 46(4):217-24 (1996)
    371979Melanoma: an overview.



    		+-nlCA Cancer J Clin 29(4):194-215 (1979)
    382008State of the science 60th anniversary review: 60 Years of advances in cutaneous melanoma epidemiology, diagnosis, and treatment, as reported in the journal Cancer.



    		+-nlCancer 113(7 Suppl):1728-43 (2008)
    392008Adjuvant radiotherapy for cutaneous melanoma.



    		+-nlCancer 112(6):1189-96 (2008)
    402007Influence of age on survival in childhood spitzoid melanomas.



    		+-nlCancer 109(8):1579-83 (2007)
    412007Chemotherapy for metastatic melanoma: time for a change?



    		+-nlCancer 109(3):455-64 (2007)
    422006Molecularly targeted therapy for melanoma: current reality and future options.



    		+-nlCancer 107(10):2317-27 (2006)
    432006Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma.



    		+-nlCancer 106(7):1431-42 (2006)
    442005Wide excision without radiation for desmoplastic melanoma.



    		+-nlCancer 104(7):1462-7 (2005)
    452000Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.



    		+-nlCancer 88(3):589-95 (2000) Marghoob AA
    461997Ultra-late recurrence (15 years or longer) of cutaneous melanoma.



    		+-nlCancer 79(12):2361-70 (1997)
    472009Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma.



    		+-nlCancer Control 16(3):240-7 (2009)
    482009Sentinel lymph node biopsy for melanoma: indications and rationale.



    		+-nlCancer Control 16(3):234-9 (2009)
    492009Pediatric melanoma: a review.



    		+-nlCancer Control 16(3):225-33 (2009)
    502009Tumor biomarkers in melanoma.



    		+-nlCancer Control 16(3):219-24 (2009)
    512009Epigenetics in human melanoma.



    		+-nlCancer Control 16(3):200-18 (2009)
    522008Treatment options for limited or symptomatic metastatic melanoma.



    		+-nlCancer Control 15(3):239-47 (2008)
    532008Radiation therapy as primary and adjuvant treatment for local and regional melanoma.



    		+-nlCancer Control 15(3):233-8 (2008)
    542008Therapy for unresectable recurrent and in-transit extremity melanoma.



    		+-nlCancer Control 15(3):225-32 (2008)
    552008Surgical management of melanoma in situ on chronically sun-damaged skin.



    		+-nlCancer Control 15(3):216-24 (2008)
    562008The impact of genomics in understanding human melanoma progression and metastasis.



    		+-nlCancer Control 15(3):202-15 (2008)
    572005Choices in adjuvant therapy of melanoma.



    		+-nlCancer Control 12(4):236-41 (2005)
    582005Sentinel node biopsy for thin melanomas: which patients should be considered?



    		+-nlCancer Control 12(4):230-5 (2005)
    592005Cutaneous melanoma: prognostic factors.



    		+-nlCancer Control 12(4):223-9 (2005)
    602004Malignant melanoma of the conjunctiva.



    		+-nlCancer Control 11(5):310-6 (2004)
    612004Choroidal melanoma: natural history and management options.



    		+-nlCancer Control 11(5):296-303 (2004)
    622002The new melanoma staging system.



    		+-nlCancer Control 9(1):9-15 (2002)
    632006Pathology of melanoma.



    		+-nlClin Cancer Res 12(7 Pt 2):2308s-2311s (2006)
    642009Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.



    		+-nlJ Natl Cancer Inst 101(7):452-74 (2009)
    652008Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010).



    		+-nlOncologist 13 Suppl 4(-):16-25 (2008)
    662008Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with tremelimumab (CP-675,206).



    		+-nlOncologist 13 Suppl 4(-):10-5 (2008)
    672007Temozolomide for the treatment of metastatic melanoma: a systematic review.



    		+-nlOncologist 12(9):1114-23 (2007)
    682004Recent advances in melanoma biology.



    		+-nlOncologist 9(2):182-7 (2004)
    692000Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma.



    		+-nlOncologist 5(2):144-51 (2000)
    702009Melanoma: molecular pathogenesis and emerging target therapies (Review).



    		+-nlInt J Oncol 34(6):1481-9 (2009)
    712006Malignant melanoma: genetics and therapeutics in the genomic era.



    		+-nlGenes Dev 20(16):2149-82 (2006)
    721980On the histological diagnosis and prognosis of malignant melanoma.



    		+-nlJ Clin Pathol 33(2):101-24 (1980)
    732004Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.



    		+-nlJAMA 292(22):2771-6 (2004)
    742006Cutaneous malignant melanoma.



    		+-nlMayo Clin Proc 81(4):500-7 (2006)
    752006Unusual variants of malignant melanoma.



    		+-nlMod Pathol 19 Suppl 2(-):S41-70 (2006)
    762007The role of interval nodes in sentinel lymph node mapping and dissection for melanoma patients.



    		+-nlJ Nucl Med 48(10):1607-13 (2007)
    772006Role of nuclear medicine in the management of cutaneous malignant melanoma.



    		+-nlJ Nucl Med 47(6):957-67 (2006)
    782006Sentinel lymph node biopsy in melanoma.



    		+-nlJ Nucl Med 47(2):191-5 (2006)
    792003Patterns of lymphatic drainage from the skin in patients with melanoma.



    		+-nlJ Nucl Med 44(4):570-82 (2003)
    802002Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0.



    		+-nlJ Nucl Med 43(10):1414-8 (2002)
    812002Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.



    		+-nlJ Nucl Med 43(6):811-27 (2002)
    821997Long-term follow-up after uveal melanoma charged particle therapy.



    		+-nlTrans Am Ophthalmol Soc 95(-):171-87; discussion 187-91 (1997)
    831995Risk factors for growth and metastasis of small choroidal melanocytic lesions.



    		+-nlTrans Am Ophthalmol Soc 93(-):259-75; discussion 275-9 (1995)
    841984The ultrastructure of conjunctival melanocytic tumors.



    		+-nlTrans Am Ophthalmol Soc 82(-):599-752 (1984)
    851980Conjunctival melanomas: prognostic factors a review and an analysis of a series.



    		+-nlTrans Am Ophthalmol Soc 78(-):467-502 (1980)
    862009Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland.



    		+-nlClin Ophthalmol 3(-):49-55 (2009)
    872007High-frequency ultrasound characteristics of 24 iris and iridociliary melanomas: before and after plaque brachytherapy.



    		+-nlArch Ophthalmol 125(8):1051-8 (2007)
    882001Transpupillary thermotherapy as an adjunct to ruthenium plaque radiotherapy for choroidal melanoma.



    		+-nlActa Ophthalmol Scand 79(1):19-22 (2001)
    891999Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients.



    		+-nlActa Ophthalmol Scand 77(4):414-7 (1999)
    902002[Choroidal melanoma: current therapeutic approaches].



    		+-nlJ Fr Ophtalmol 25(2):203-11 (2002)
    911998From the outside in, or the inside out. Resecting uveal melanomas.



    		+-nlBr J Ophthalmol 82(3):209 (1998)
    921997Retinoinvasive malignant melanoma of the uvea.



    		+-nlBr J Ophthalmol 81(8):691-7 (1997)
    932009Molecular pathways supporting the proliferation staging of malignant melanoma (review).



    		+-nlInt J Mol Med 24(3):295-301 (2009)
    941990CT of malignant melanoma in the chest, abdomen, and musculoskeletal system.



    		+-nlRadiographics 10(4):603-20 (1990)
    952007The role of sentinel lymph node biopsy in the management of melanoma.



    		+-nlAdv Surg 41(-):241-56 (2007)
    962011Angiogenesis and melanoma - from basic science to clinical trials.



    		+-nlAm J Cancer Res 1(7):852-68 (2011)
    972011Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects.



    		+-nlAm J Cancer Res 1(7):913-24 (2011)
    982010Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 21 Suppl 5(-):v194-7 (2010)
    992010Advances in systemic treatment of melanoma.



    		+-nlAnn Oncol 21 Suppl 7(-):vii339-44 (2010)
    1002009Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 20 Suppl 4(-):129-31 (2009)
    1012002Cellular and molecular biology of human melanoma.



    		+-nlCancer Biol Ther 1(1):14-7 (2002)
    1022010Survival and the sentinel lymph node in melanoma.



    		+-nlAnn Surg Oncol 17(1):18-20 (2010) Faries M
    1032008Understanding signaling cascades in melanoma.



    		+-nlPhotochem Photobiol 84(2):289-306 (2008)
    1042004Biological functions of melanoma-associated antigens.



    		+-nlWorld J Gastroenterol 10(13):1849-53 (2004)
    1052011Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.



    		+-nlMayo Clin Proc 86(6):522-8 (2011)
    1062008Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.



    		+-nlRadiology 249(3):836-44 (2008)
    1072010The biology of melanoma prognostic factors.



    		+-nlDiscov Med 10(50):87-93 (2010)
    1082007Viewing malignant melanoma cells as macrophage-tumor hybrids.



    		+-nlCell Adh Migr 1(1):2-6 (2007)
    1092006Chemotherapy and targeted therapy combinations in advanced melanoma.



    		+-nlClin Cancer Res 12(7 Pt 2):2366s-2370s (2006)
    1102010Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma.



    		+-nlClin Cancer Res 16(3):1042-8 (2010)
    1112009Metabolic approaches to treatment of melanoma.



    		+-nlClin Cancer Res 15(21):6490-4 (2009)
    1122008Integrative genomic analysis of aneuploidy in uveal melanoma.



    		+-nlClin Cancer Res 14(1):115-22 (2008)
    1132010Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety.



    		+-nlOncologist 15(4):416-27 (2010)
    1142009What is the role of cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma?



    		+-nlOncologist 14(8):848-61 (2009)
    1152010BRAF, a target in melanoma: implications for solid tumor drug development.



    		+-nlCancer 116(21):4902-13 (2010)
    1162010Determinants of survival in patients with brain metastases from cutaneous melanoma.



    		+-nlBr J Cancer 102(8):1213-8 (2010)
    1172009Integrating BRAF/MEK inhibitors into combination therapy for melanoma.



    		+-nlBr J Cancer 100(3):431-5 (2009)
    1182006Technologies for the diagnosis of primary melanoma of the skin.



    		+-nlMed J Aust 185(10):533-4 (2006)
    1192005Clinicopathological features of and risk factors for multiple primary melanomas.



    		+-nlJAMA 294(13):1647-54 (2005)
    1202010Ultraviolet a light: potential underlying causes of melanoma.



    		+-nlFuture Oncol 6(10):1523-6 (2010)
    1212008Emerging insights into the molecular pathogenesis of uveal melanoma.



    		+-nlFuture Oncol 4(5):629-36 (2008)
    1222006Imaging of metastatic melanoma.



    		+-nlCancer Imaging 6(-):204-8 (2006)
    1232009Melanoma: promising new discoveries and treatment modalities for difficult clinical scenarios - part II.



    		+-nlCancer Control 16(3):196-7 (2009)
    1242006Prognosticators of melanoma, the melanoma report, and the sentinel lymph node.



    		+-nlMod Pathol 19 Suppl 2(-):S71-87 (2006)
    1252006The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment.



    		+-nlMod Pathol 19 Suppl 2(-):S21-33 (2006)
    1262003Grading of atypia in nevi: correlation with melanoma risk.



    		+-nlMod Pathol 16(8):764-71 (2003)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.